Protein-protein interaction discovery unveils Down syndrome’s molecular mechanism potential

Down syndrome, a congenital disorder stemming from abnormal cell division and differentiation, is most common in newborns fated to neurodevelopmental delays and other health complications. The genetic defect causes the dysfunction of the protein kinase DYRK1A, which is encoded on chromosome 21 and is deeply associated with both Down syndrome and autism spectrum disorder. DYRK1A has attracted attention as a target molecule for treating various diseases. Researchers have now identified the FAM53C protein and its DYRK1A-inhibiting effect that keeps the protein kinase inactive inside the cytoplasm.

The pedigree of brain cells

The superior colliculus in the mammalian brain takes on many important tasks by making sense of our environment. Any mistakes during the development of this brain region can lead to severe neurological disorders. Scientists have now delineated the pedigree and origin of nerve cells that make up the superior colliculus.

Glial tone of aggression

While anger and aggression are instinctive behaviors found across many species, leaving these emotions unchecked can lead to conflict and violence. In a recent study, researchers demonstrated that neuronal-glial interactions in the cerebellum determine the degree of aggression exhibited by mice. This suggests that future therapeutic methods could adjust glial activity in the cerebellum to help reduce unwanted aggression.

People with autism less likely to succumb to bystander effect, research finds

A well-established psychological theory states that most of us are less likely to intervene in a bad situation if other people are present, and this 'bystander effect' also applies to workplace settings. However, new research shows that people with autism are less likely to be affected by this social contagion than neurotypical people. They are less likely to stay silent in the face of gross misconduct or even just everyday mistakes, pointing to the positive aspects of autism and how organizations can benefit from hiring more neurodivergent people, findings reveal.

New clues to early development of schizophrenia

Schizophrenia is a severe neuropsychiatric disease that remains poorly understood and treated. Schizophrenia onset is typically in adolescence or early adulthood, but its underlying causes are thought to involve neurodevelopmental abnormalities. Because human prenatal and postnatal brain tissue is exceedingly difficult to procure and therefore study, researchers have had limited opportunities to identify early disease mechanisms, especially during the critical prenatal period. Now, a pair of studies use new technology to study schizophrenia in models of early human brain development.